Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Head & Neck 2Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Thyroid Cancer, Papillary 1Carcinoma, Medullary 1

Interventions

Everolimus 25Magnetic Resonance Spectroscopy 13pembrolizumab 12pasireotide 12Sunitinib 11Octreotide 11lanreotide 10cabozantinib 10lenvatinib 8Sorafenib 8Cisplatin 8Temozolomide 7Etoposide 7Bevacizumab 7pazopanib 6Paclitaxel 6Nivolumab 6Doxorubicin 6Carboplatin 6Capecitabine 6vandetanib 5gallium Ga 68 dotatate 5Specimen Handling 5trametinib 4lutetium Lu 177 dotatate 4dabrafenib 4Mitotane 4Iodine-131 4telotristat ethyl 3surufatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ferrosoferric Oxide × Endocrine × Clear all
NCT01927887 2017-06-06

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Massachusetts General Hospital

Phase NA Completed
12 enrolled 6 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡